MAG Optics is an early stage, ophthalmic medical device. We specialize in innovation and development of ground-breaking, patent-pending technologies. Our flagship technology, corneal implants, provides a surgical solution to treat visual conditions, such as Keratoconus and other corneal disorders. We are pioneering the first patient-centric corneal shaping platform which allows for vision correction in Keratoconus as well as other conditions like Presbyopia and Astigmatism. Keratoconus is a rare, degenerative eye disease of the central cornea. The cornea, which is normally dome-shaped begins to thin irregularly and bulge into a cone-like shape. We are have conducted human feasibility studies in over 20+ eyes. Founded in 2014, the company is based in the US and UK.